Matt Might receives White House Appointment

March 29, 2016

Professor Matt Might has joined the Executive Office of the President at the White House to serve as an Advisor for the Precision Medicine Initiative. In this role, Matt will deploy his broad expertise in computer science and genomic medicine toward a successful launch and scaling of the President’s Precision Medicine Initiative.

Spearheaded by Professor Might, whose son has a rare disease, the Patient Empowered Precision Medicine Alliance (PEPMA) joins researchers from the University of Utah College of Pharmacy, School of Medicine, School of Computing and University of Utah spin-out biotech company Recursion Pharmaceuticals with researchers from Boston’s Children’s Hospital, Harvard Medical School and Pairnomix LLC. The project will lay the groundwork for a pipeline that rapidly matches patients with the right drugs for their condition, at a relatively low cost.

To read more about the Patient Empowered Precision Medicine Alliance and Professor Might’s involvement read here.